Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 98(23): 12960-5, 2001 Nov 06.
Artículo en Inglés | MEDLINE | ID: mdl-11687630

RESUMEN

Transcriptional repressors can be classified as short- or long-range, according to their range of activity. Functional analysis of identified short-range repressors has been carried out largely in transgenic Drosophila, but it is not known whether general properties of short-range repressors are evident in other types of assays. To study short-range transcriptional repressors in cultured cells, we created chimeric tetracycline repressors based on Drosophila transcriptional repressors Giant, Drosophila C-terminal-binding protein (dCtBP), and Knirps. We find that Giant and dCtBP are efficient repressors in Drosophila and mammalian cells, whereas Knirps is active only in insect cells. The restricted activity of Knirps, in contrast to that of Giant, suggests that not all short-range repressors possess identical activities, consistent with recent findings showing that short-range repressors act through multiple pathways. The mammalian repressor Kid is more effective than either Giant or dCtBP in mammalian cells but is inactive in Drosophila cells. These results indicate that species-specific factors are important for the function of the Knirps and Kid repressors. Giant and dCtBP repress reporter genes in a variety of contexts, including genes that were introduced by transient transfection, carried on episomal elements, or stably integrated. This broad activity indicates that the context of the target gene is not critical for the ability of short-range repressors to block transcription, in contrast to other repressors that act only on stably integrated genes.


Asunto(s)
Proteínas Represoras/metabolismo , Animales , Secuencia de Bases , Cartilla de ADN , Drosophila , Células HeLa , Proteína Vmw65 de Virus del Herpes Simple/genética , Proteína Vmw65 de Virus del Herpes Simple/metabolismo , Humanos , Regiones Promotoras Genéticas , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Proteínas Represoras/genética
2.
Methods Find Exp Clin Pharmacol ; 23(2): 73-7, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11484413

RESUMEN

Adenosine triphosphate (ATP) has been shown to stimulate mucin release by activation of protein kinase C (PKC) following activation of phospholipase C (PLC) coupled to the P2 receptor via G-proteins. The aim of the present study was to investigate pathways downstream to the PKC activation in ATP-induced mucin release from primary hamster tracheal surface epithelial (HTSE) cells. The release of mucin was determined by chromatographic procedure after metabolic labeling of mucin with [3H]-glucosamine. The results were: i) ATP induced the release of arachidonic acid, which caused the release of mucin. Pretreatment with mepacrine (0.3 mM), a phospholipase A2 (PLA2) inhibitor, inhibited the ATP-induced arachidonic acid and mucin release. Oleoyloxyethylphosphocholine, another PLA2 inhibitor, gave similar results. ii) An activator of PKC, 4 beta-phorbol-12 alpha-myristate-13-acetate (PMA, 1 microM) induced mucin release, which was inhibited by mepacrine pretreatment. iii) Downregulation of PKC by prolonged (16 h) PMA treatment caused inhibition of ATP-induced mucin release. Treatment of PKC downregulated HTSE cells with mepacrine did not further decrease the ATP-induced mucin release. These results suggest that PLA2 is involved in ATP-induced mucin release and its activation is sequential to the PLC-PKC pathway.


Asunto(s)
Adenosina Trifosfato/farmacología , Células Caliciformes/efectos de los fármacos , Fosfolipasas A/metabolismo , Análisis de Varianza , Animales , Células Cultivadas , Cricetinae , Activación Enzimática , Inhibidores Enzimáticos/farmacología , Células Caliciformes/metabolismo , Masculino , Mesocricetus , Mucinas/metabolismo , Fosfolipasas A/antagonistas & inhibidores , Fosfolipasas A2 , Proteína Quinasa C/metabolismo , Quinacrina/farmacología , Tráquea/efectos de los fármacos , Tráquea/metabolismo
3.
Brain Res ; 902(2): 198-204, 2001 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-11384613

RESUMEN

In this study we investigated the effect of immunostimulation on intracellular ATP level in rat glial cells. Rat primary astrocytes or C6 glioma cells were treated for 48 h with IFN-gamma, LPS or IFN-gamma plus LPS. These treatments increased NO production from the cells and a synergistic increase in NO production was observed with IFN-gamma plus LPS. Intracellular ATP level was decreased to about half the control level at the highest concentration of IFN-gamma (100 U/ml) plus LPS (1 microg/ml) without affecting cell viability. The level of intracellular ATP was inversely correlated with the extent of NO production from the glial cells. The increase in NO production is at least 6 h ahead of the initiation of ATP depletion, and NOS inhibitor N(G)-nitro-L-arginine (NNA) or Nomega-nitro-L-arginine methyl ester (L-NAME) inhibited NO production and ATP depletion. Exogenous addition of peroxynitrite generator 3-morpholinosydnonimine (SIN-1) and to a lesser extent NO generator S-nitroso-N-acetylpenicillamine (SNAP) depleted intracellular ATP level in a dose-dependent manner. The results from the present study imply that immunostimulation of rat glial cells decreases the intracellular ATP level without affecting cell viability. Considering the role of astrocytes as an essential regulator of the extracellular environment in the brain, the immunostimulation-induced decrease in intracellular ATP level may participate in the pathogenesis of various neurological diseases.


Asunto(s)
Adenosina Trifosfato/metabolismo , Astrocitos/efectos de los fármacos , Sistema Nervioso Central/efectos de los fármacos , Encefalitis/metabolismo , Mediadores de Inflamación/farmacología , Líquido Intracelular/efectos de los fármacos , Óxido Nítrico/metabolismo , Animales , Animales Recién Nacidos , Astrocitos/inmunología , Astrocitos/metabolismo , Sistema Nervioso Central/inmunología , Sistema Nervioso Central/metabolismo , Relación Dosis-Respuesta a Droga , Encefalitis/inmunología , Encefalitis/fisiopatología , Inhibidores Enzimáticos/farmacología , Interferón gamma/farmacología , Líquido Intracelular/inmunología , Líquido Intracelular/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Lipopolisacáridos/farmacología , Molsidomina/análogos & derivados , Molsidomina/farmacología , NG-Nitroarginina Metil Éster/farmacología , Nitratos/metabolismo , Óxido Nítrico Sintasa/metabolismo , Nitroarginina/farmacología , Penicilamina/análogos & derivados , Penicilamina/farmacología , Ratas , Ratas Sprague-Dawley , S-Nitroso-N-Acetilpenicilamina , Células Tumorales Cultivadas
4.
Hybridoma ; 20(2): 123-9, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11394531

RESUMEN

Airway mucins are high molecular mass (>10(6) dalton) glycoproteins with various types of associated molecules including glycoproteins, lipoproteins, and lipids. The study of mucin-associated proteins is limited largely due to the lack of specific probes. In this study, we produced a monoclonal antibody, MAbHT10, against a 190-kDa mucin associated-protein by immunizing mice with hamster airway mucin purified in nondissociative condition. Using HT10, the 190-kDa mucin-associated protein was characterized immunologically. The 190-kDa mucin-associated protein is glycoprotein and HT10 recognized carbohydrate containing portion of the protein. The association of 190-kDa protein with mucin is strong enough that heat and detergent treatment is required to dissociate it from mucin as evidenced by gel filtration chromatography, Western blot, enzyme-linked immunoadsorbent assay (ELISA), and co-immunoprecipitation. The expression of the 190-kDa protein is increased with the development of hamster tracheal epithelial cells in culture, but showed differences with the pattern of the regulation of mucin expression. Adenosine triphosphate (ATP), a known strong mucin secretagogue, dose-dependently increased mucin release but caused only marginal increase in the release of the 190-kDa protein. The MAb should be useful in the structural and functional analysis of the 190-kDa mucin-associated proteins in physiological and pathological situations such as chronic airway diseases.


Asunto(s)
Células Epiteliales/química , Glicoproteínas/inmunología , Glicoproteínas/metabolismo , Mucinas/metabolismo , Tráquea/química , Adenosina Trifosfato/farmacología , Animales , Anticuerpos Monoclonales/biosíntesis , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/aislamiento & purificación , Técnicas de Cultivo de Célula , Cricetinae , Detergentes/farmacología , Células Epiteliales/citología , Epítopos/análisis , Regulación de la Expresión Génica , Calor , Ratones , Peso Molecular , Pruebas de Precipitina , Unión Proteica/efectos de los fármacos , Tráquea/citología
5.
AIDS Res Hum Retroviruses ; 16(17): 1797-804, 2000 Nov 20.
Artículo en Inglés | MEDLINE | ID: mdl-11118065

RESUMEN

Fusion between the envelope of HIV and the plasma membrane of target cells is mediated by gp41, the envelope glycoprotein of HIV. Peptides derived from the membrane-proximal helical motif of the extracellular domain of gp41 effectively inhibit the infection of HIV, and their inhibitory activities are known to be correlated with the helical propensity of the peptides. We have designed small peptides that can form a stable alpha helix and thereby inhibit gp120/41-mediated cell fusion. A 19-mer peptide from the membrane-proximal helical motif of gp41 had no secondary structure in solution, and failed to block gp41-mediated cell fusion. When amino acids with low helical propensity were substituted, and helix-capping sequences were introduced at both ends of the peptides, the modified peptides formed a stable helical structure. They also bound to the coiled-coil motif of gp41 presented at the C terminus of thioredoxin and blocked the cell fusion mediated by gp120/41. These results implied that such modification was enough to change a short peptide derived from gp41 into a potent inhibitor against the infection of HIV.


Asunto(s)
Diseño de Fármacos , Proteína gp41 de Envoltorio del VIH/fisiología , VIH-1/fisiología , Fusión de Membrana/efectos de los fármacos , Péptidos/farmacología , Ingeniería de Proteínas , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Técnicas Biosensibles , Línea Celular , Dicroismo Circular , Proteína gp41 de Envoltorio del VIH/química , VIH-1/efectos de los fármacos , Humanos , Datos de Secuencia Molecular , Péptidos/síntesis química , Péptidos/química , Estructura Secundaria de Proteína
6.
Eur J Pharmacol ; 396(2-3): 53-8, 2000 May 19.
Artículo en Inglés | MEDLINE | ID: mdl-10822056

RESUMEN

The genetically epilepsy-prone rat (GEPR) seizure model is characterized by extensive abnormalities in brain noradrenergic function. Earlier studies had suggested that GEPRs might not regulate adrenoceptors in a normal fashion. The purpose of the present study was to determine if GEPR-9s are capable of up and down regulation of alpha(1)- and beta-adrenoceptors in response to increments or decrements in extracellular norepinephrine. Seizure induction has been shown to increase extracellular norepinephrine. Chronic sound or electroshock-induced seizures caused down regulation of beta-adrenoceptors in frontal cortex and in hippocampus from GEPR-9s. Similarly, chronic daily treatment with the norepinephrine reuptake inhibitor desmethylimipramine produced down regulation of beta-adrenoceptors in frontal cortex and in hippocampus from GEPR-9s. As is the case in neurologically normal animals, chronic electroshock-induced seizure did not cause down regulation of beta-adrenoceptors in 6-hydroxydopamine pretreated GEPR-9s. Chronic electroshock treatment also caused up-regulation of alpha(1)-adrenoceptors in frontal cortex but not in hippocampus. In 6-hydroxydopamine pretreated GEPR-9s, chronic electroshock treatment caused a further up-regulation of alpha(1)-adrenoceptors in frontal cortex but not in hippocampus. Taken together, these results indicate that GEPR-9s are capable of up and down regulation of alpha(1)- and beta-adrenoceptors in a manner that is qualitatively similar to the regulation of these receptors in normal animals. Whether the regulation of brain adrenoceptors is quantitatively different in GEPRs from normal animals remains to be established.


Asunto(s)
Norepinefrina/fisiología , Receptores Adrenérgicos alfa 1/análisis , Receptores Adrenérgicos beta/análisis , Convulsiones/metabolismo , Animales , Dihidroalprenolol/metabolismo , Electrochoque , Epilepsia/etiología , Epilepsia/genética , Norepinefrina/metabolismo , Oxidopamina , Prazosina/metabolismo , Ratas , Ratas Sprague-Dawley
7.
J Neurochem ; 74(5): 1989-98, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10800942

RESUMEN

Previously we reported that immunostimulated astrocytes were highly vulnerable to glucose deprivation. The augmented death was mimicked by the peroxynitrite (ONOO )-producing reagent 3-morpholinosydnonimine (SIN-1). Here we show that glucose deprivation and ONOO- synergistically deplete intracellular reduced glutathione (GSH) and augment the death of astrocytes via formation of cyclosporin A-sensitive mitochondrial permeability transition (MPT) pore. Astrocytic GSH levels were only slightly decreased by glucose deprivation or SIN-1 (200 microM) alone. In contrast, a rapid and large depletion of GSH was observed in glucose-deprived/ SIN-1-treated astrocytes. The depletion of GSH occurred before a significant release of lactate dehydrogenase (a marker of cell death). Superoxide dismutase and ONOO-scavengers completely blocked the augmented death, indicating that the reaction of nitric oxide with superoxide to form ONOO was implicated. Furthermore, nitrotyrosine immunoreactivity (a marker of ONOO-) was markedly enhanced in glucose-deprived/SIN-1 -treated astrocytes. Mitochondrial transmembrane potential (MTP) was synergistically decreased in glucose-deprived/SIN-1-treated astrocytes. The glutathione synthase inhibitor L-buthionine-(S,R)-sulfoximine markedly decreased the MTP and increased lactate dehydrogenase (LDH) releases in SIN-1-treated astrocytes. Cyclosporin A, an MPT pore blocker, completely prevented the MTP depolarization as well as the enhanced LDH releases in glucose-deprived/SIN-1-treated astrocytes.


Asunto(s)
Astrocitos/metabolismo , Glucosa/deficiencia , Glutatión/deficiencia , Nitratos/farmacología , Animales , Astrocitos/fisiología , Supervivencia Celular/efectos de los fármacos , Sinergismo Farmacológico , Glutatión/análogos & derivados , Glutatión/farmacología , Potenciales de la Membrana/efectos de los fármacos , Mitocondrias/fisiología , Molsidomina/análogos & derivados , Molsidomina/farmacología , Donantes de Óxido Nítrico/farmacología , Compuestos Nitrosos/farmacología , Penicilamina/análogos & derivados , Penicilamina/farmacología , Ratas , Ratas Sprague-Dawley , S-Nitroso-N-Acetilpenicilamina , S-Nitrosoglutatión
8.
Brain Res Bull ; 53(6): 777-82, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11179842

RESUMEN

The genetically epilepsy-prone rat (GEPR) is a model of generalized tonic/clonic epilepsy, and has functional noradrenergic deficiencies that act as partial determinants for the seizure predisposition and expression. The present study investigated the effect of repeated seizure experiences by acoustic stimulation (110 dB, 10 times) on the immunoreactivities of tyrosine hydroxylase (TH), a rate-determining enzyme in the synthesis of norepinephrine, in brain regions of GEPRs. TH immunoreactivity in locus coeruleus, the major noradrenergic nucleus in brain, was lower in GEPRs than control Sprague-Dawley rats. It was also decreased in several regions including inferior colliculus of GEPRs. Repeated experiences of audiogenic seizures further decreased TH immunoreactivities in locus coeruleus and inferior colliculus of GEPRs. The results from the present study suggest that the lower immunoreactivities of TH in locus coeruleus and inferior colliculus contribute, at least in part, to the noradrenergic deficits in GEPRs, and repeated seizure experiences further intensified these noradrenergic deficits, which may be related to the altered seizure expression by repetitive audiogenic seizure in GEPRs.


Asunto(s)
Encéfalo/enzimología , Epilepsia/enzimología , Neuronas/enzimología , Norepinefrina/metabolismo , Tirosina 3-Monooxigenasa/metabolismo , Animales , Encéfalo/patología , Encéfalo/fisiopatología , Modelos Animales de Enfermedad , Epilepsia/patología , Epilepsia/fisiopatología , Inmunohistoquímica , Colículos Inferiores/enzimología , Colículos Inferiores/patología , Colículos Inferiores/fisiopatología , Locus Coeruleus/enzimología , Locus Coeruleus/patología , Locus Coeruleus/fisiopatología , Masculino , Neuronas/patología , Ratas , Ratas Mutantes/metabolismo , Ratas Sprague-Dawley , Convulsiones/enzimología , Convulsiones/patología , Convulsiones/fisiopatología
9.
Biochem Biophys Res Commun ; 265(3): 625-9, 1999 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-10600471

RESUMEN

Peptides derived from gp41 effectively block the gp41-mediated cell fusion or HIV infection. A 36-mer (naDP178), 51-mer (C51) and 27-mer peptide (C27) from the membrane proximal region of gp41 have been examined their interaction modes with the coiled-coil motif of gp41 presented in thioredoxin (Trx-N) or the bacterially expressed ectodomain of gp41 (Ec-gp41ec). All of these peptides effectively inhibited the gp41-mediated membrane fusion, however, they showed distinct interaction modes with Ec-gp41ec or Trx-N. C51 peptide bound tightly to Trx-N, and it increased the solubility of Ec-gp41ec. naDP178 showed very weak binding affinity to Trx-N, however, it effectively solubilized Ec-gp41ec. In contrast, C27 peptide showed significant binding to Trx-N; however, it did not affect the solubility of Ec-gp41ec. These interaction modes of C-peptides were assumed to be related to their different inhibitory mechanism against gp41-mediated cell fusion.


Asunto(s)
Proteína gp41 de Envoltorio del VIH/metabolismo , Infecciones por VIH/etiología , VIH-1/patogenicidad , Fusión de Membrana/fisiología , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Sitios de Unión , Escherichia coli/genética , Proteína gp41 de Envoltorio del VIH/química , Proteína gp41 de Envoltorio del VIH/genética , Infecciones por VIH/metabolismo , Infecciones por VIH/virología , VIH-1/genética , VIH-1/metabolismo , Humanos , Datos de Secuencia Molecular , Fragmentos de Péptidos/química , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/metabolismo , Unión Proteica , Estructura Secundaria de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Solubilidad , Tiorredoxinas/metabolismo
10.
Toxicology ; 133(2-3): 105-13, 1999 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-10378477

RESUMEN

Many neurological disorders that occur frequently in lead intoxicated animals, have also been observed in thiamine deficient animals. To test whether lead intoxication could decrease the thiamine status and thresholds of electroshock seizure in rats, 3-week-old Wistar rats were treated with lead or lead plus thiamine. For comparison, a thiamine deficient group was included. Thiamine contents and transketolase activity, one of the thiamine dependent enzymes in the brain regions were significantly lowered by lead intoxication and thiamine deficiency. In both cases, thresholds of the electroshock seizure were significantly decreased. Thiamine supplementation reversed these signs and decreased the brain lead concentration in the lead treated group. The results from the present study suggest that the increased seizure susceptibility induced by lead intoxication in rats may be mediated at least in part through the changes of thiamine status.


Asunto(s)
Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Plomo/toxicidad , Convulsiones/etiología , Deficiencia de Tiamina/inducido químicamente , Deficiencia de Tiamina/fisiopatología , Animales , Encéfalo/enzimología , Relación Dosis-Respuesta a Droga , Electrochoque , Femenino , Plomo/farmacocinética , Ratas , Ratas Wistar , Convulsiones/inducido químicamente , Convulsiones/enzimología , Tiamina/farmacología , Deficiencia de Tiamina/enzimología , Transcetolasa/metabolismo
11.
Exp Neurol ; 156(1): 84-91, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10192779

RESUMEN

The epileptic condition of the genetically epilepsy-prone rat (GEPR) appears to be caused partially by deficiencies in the locus coeruleus (LC) innervation of the superior colliculus (SC). Previous studies provide quantitative documentation of noradrenergic morphological deficits in the moderately epileptic GEPR-3. The present findings extend these studies by applying cell culture methodology to assessments of the severely epileptic GEPR-9. Our data show that total neurite length, the number of neurite branch points per cell, the cross-sectional area of cell bodies, and the cell perimeter are deficient in noradrenergic neurons in LC + SC cocultures derived exclusively from GEPR-9s compared to analogous cocultures obtained solely from nonepileptic control rats. Partial restoration of LC neuron morphology toward normal occurs when the GEPR-9 SC component of the coculture is replaced with nonepileptic control SC. Finally, when the GEPR-9 SC is cocultured with the control LC, a partial morphological deficit occurs in the otherwise normal noradrenergic neurons. However, the magnitude of this deficit is less than that observed in noradrenergic neurons of the GEPR-9 LC cocultured with the control SC. These data support the hypothesis that the developmental deficiencies of noradrenergic neurons of the GEPR-9 are derived from two sources, the LC and its target tissue, in this case, the SC. Also, intrinsic abnormalities of the LC appear to make a more pronounced contribution to the noradrenergic deficits than do those which reside in the SC.


Asunto(s)
Epilepsia/patología , Locus Coeruleus/patología , Neuronas/patología , Norepinefrina/metabolismo , Colículos Superiores/patología , Animales , Técnicas de Cocultivo , Técnicas de Cultivo , Epilepsia/genética , Femenino , Inmunohistoquímica , Locus Coeruleus/anomalías , Locus Coeruleus/ultraestructura , Neuritas/ultraestructura , Neuronas/metabolismo , Neuronas/ultraestructura , Embarazo , Ratas , Ratas Sprague-Dawley , Colículos Superiores/anomalías , Colículos Superiores/ultraestructura
12.
Mol Cells ; 8(6): 717-23, 1998 Dec 31.
Artículo en Inglés | MEDLINE | ID: mdl-9895125

RESUMEN

The transmembrane protein of HIV-1, gp41, mediates fusion between membranes of the virus and target cell. Strong interaction between the helical regions in the ectodomain of gp41 has been exploited to develop a method that can detect a potential inhibitor against gp41. The N-terminus coiled-coil or the C-terminus helical sequences within the ectodomain of gp41 were inserted into the C-terminus of thioredoxin (Trx) or glutathione S-transferase (GST) to generate the fusion proteins, Trx-N and GST-C, respectively. The inserted sequences of GST-C and Trx-N cause the two proteins to interact with each other and to form a complex. Furthermore, GST-C binds specifically to the surface-coated Trx-N, and the amount of attached GST-C is detected by an ELISA assay using anti-GST antibodies. Peptides derived from the helical regions of gp41 compete with GST-C for binding to Trx-N as well as prevent the gp41-mediated cell fusion. This in vitro assay system can be applied to screening compounds that have an inhibitory activity against gp41.


Asunto(s)
Fármacos Anti-VIH/aislamiento & purificación , Proteína gp41 de Envoltorio del VIH/efectos de los fármacos , Secuencia de Aminoácidos , Fármacos Anti-VIH/metabolismo , Fármacos Anti-VIH/farmacología , Unión Competitiva , Fusión Celular/efectos de los fármacos , Ensayo de Inmunoadsorción Enzimática , Glutatión Transferasa/genética , Glutatión Transferasa/metabolismo , Proteína gp41 de Envoltorio del VIH/genética , Proteína gp41 de Envoltorio del VIH/metabolismo , Células HeLa , Humanos , Fusión de Membrana/efectos de los fármacos , Datos de Secuencia Molecular , Fragmentos de Péptidos/metabolismo , Fragmentos de Péptidos/farmacología , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Tiorredoxinas/genética , Tiorredoxinas/metabolismo
13.
Extremophiles ; 1(3): 125-34, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9680318

RESUMEN

Aquifex pyrophilus is one of the hyperthermophilic bacteria that can grow at temperatures up to 95 degrees C. To obtain information about its genomic structure, random sequencing was performed on plasmid libraries containing 0.5-2 kb genomic DNA fragments of A. pyrophilus. Comparison of the obtained sequence tags with known proteins revealed that 123 tags showed strong similarity to previously identified proteins in the PIR or Genebank databases. These included three proteases, two amino acid racemases, and three enzymes utilizing oxygen as substrate. Although the GC ratio of the genome is about 40%, the codon usage of A. pyrophilus showed biased occurrence of G and C at the third position of codons, especially those for amino acids such as asparagine, aspartic acid, cysteine, glutamine, glutamic acid, histidine, lysine, and tyrosine. A higher ratio of positively charged amino acids in A. pyrophilus proteins as compared with proteins from mesophiles suggested that Aquifex proteins might contain increased ion-pair interaction that could help to maintain heat stability.


Asunto(s)
ADN Bacteriano/análisis , Bacilos y Cocos Aerobios Gramnegativos/genética , Secuencia de Aminoácidos , Clonación Molecular , Genoma Bacteriano , Biblioteca Genómica , Datos de Secuencia Molecular , Análisis de Secuencia de ADN
14.
FEBS Lett ; 406(1-2): 142-6, 1997 Apr 07.
Artículo en Inglés | MEDLINE | ID: mdl-9109405

RESUMEN

A superoxide dismutase (SOD) gene of Aquifex pyrophilus, a marine hyperthermophilic bacterium, was cloned, sequenced, expressed in Escherichia coli, and its gene product characterized. This is the first SOD from a hyperthermophilic bacterium that has been cloned. It is an iron-containing homo-oligomeric protein with a monomeric molecular mass of 24.2 kDa. The DNA-derived amino acid sequence is more similar to those of known Mn- and Fe-SODs from thermophilic archaea than of Cu, Zn-SODs. The metal binding residues found in all SOD sequences from different species are also conserved in A. pyrophilus SOD. The protein is biochemically active only as an oligomer and is resistant to thermal denaturation.


Asunto(s)
Bacterias Aerobias Gramnegativas/enzimología , Superóxido Dismutasa/genética , Secuencia de Aminoácidos , Secuencia de Bases , Clonación Molecular , Grupo Citocromo c/metabolismo , ADN Recombinante , Estabilidad de Enzimas , Bacterias Aerobias Gramnegativas/genética , Calor , Datos de Secuencia Molecular , Superóxido Dismutasa/aislamiento & purificación , Superóxido Dismutasa/metabolismo
15.
Nucleic Acids Res ; 25(4): 794-9, 1997 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-9016631

RESUMEN

The DRE/DREF system plays an important role in transcription of DNA replication genes such as those encoding the 180 and 73 kDa subunits of DNA polymerase alpha as well as that for encoding PCNA. In this study, we found two sequences homologous to DRE (5'-TATCGATA-3') in the 5'-flanking region (-370 to -357 with respect to the transcription initiation site) of the D-raf gene and confirmed transcriptional activity through gel mobility shift assays, transient CAT assays, and spatial patterns of lacZ expression in transgenic larval tissues carrying D-raf and lacZ fusion genes. Further, we demonstrated that the D-raf gene is another target of the Zerknüllt (Zen) protein with observation of D-raf repression by Zen protein in cultured cells and its ectopic expression in the dorsal region of the homozygous zen mutant embryo. The evidence of DRE/DREF involvement in regulation of the D-raf gene obtained in this study strongly supports the idea that the DRE/DREF system is responsible for the coordinated regulation of cell proliferation-related genes in Drosophila.


Asunto(s)
Replicación del ADN , Proteínas de Drosophila , Proteínas Serina-Treonina Quinasas/genética , Proteínas Proto-Oncogénicas/genética , Proto-Oncogenes , Factores de Transcripción/genética , Transcripción Genética , Animales , Cloranfenicol O-Acetiltransferasa/genética , Drosophila melanogaster , Proteínas de Homeodominio/farmacología , Regiones Promotoras Genéticas/efectos de los fármacos , Proteínas Proto-Oncogénicas c-raf , Proteínas Represoras/farmacología , Transcripción Genética/efectos de los fármacos
16.
Life Sci ; 58(4): 259-66, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8538363

RESUMEN

The GEPR model is composed of two independently derived strains of rats each characterized by a broad-based seizure predisposition. Moderate seizure GEPRs (GEPR-3s) exhibit generalized clonus with loss of righting reflex in response to a standardized sound stimulus. The same stimulus in severe seizure GEPRs (GEPR-9s) produces a tonic-clonic convulsion much like that produced by supramaximal electroshock. The numeric descriptors (3 and 9) derive from the ordinal rating scale developed by Jobe and coworkers for evaluation of convulsion intensity. GEPRs experience an anticonvulsant effect in response to all established and many experimental antiepileptic drugs and distinctions between the classes of drugs can be made. Since serotonin plays an anticonvulsant role in nearly all animal seizure models, we examined the effects of antiepileptic drugs on serotonin using microdialysis. Among clinically effective anticonvulsants, carbamazepine, antiepilepsirine (used in China) and loreclezole produced dose-related anticonvulsant effects and increases in extracellular serotonin in GEPRs. Similarly, drugs known to block serotonin reuptake and increase extracellular serotonin (fluoxetine and sertraline) produce dose related anticonvulsant effects in GEPRs and other animal models. Accentuation of serotonin release by treating GEPRs with fluoxetine and 5-hydroxytryptophan enhances the anticonvulsant effect produced by fluoxetine. Depletion of serotonin greatly decreased the anticonvulsant effect produced by carbamazepine, antiepilepsirine and fluoxetine. Phenytoin produced a dose related anticonvulsant effect in GEPRs but did not increase extracellular serotonin. Depletion of serotonin did not diminish the anticonvulsant effect produced by phenytoin. Thus, serotonin appears to play a role in the anticonvulsant effect of several but not all anticonvulsant drugs.


Asunto(s)
Anticonvulsivantes/farmacología , Encéfalo/efectos de los fármacos , Epilepsia/tratamiento farmacológico , Epilepsia/genética , Agonistas de Receptores de Serotonina/metabolismo , Serotonina/metabolismo , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Ratas , Convulsiones/tratamiento farmacológico , Convulsiones/genética
17.
Jpn J Genet ; 69(1): 21-33, 1994 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8037925

RESUMEN

DNA polymerase beta (pol beta) cDNA of rat fused to an enhancer-promoter region plus a poly(A) signal sequence of actin 5C gene of Drosophila (abbreviated pol beta) was transferred to the Drosophila genome. Three of four constructed transgenic strains possessing transgene pol beta on different chromosomes were studied. Levels of the pol beta transcript and those of the polymerization activity of pol beta were markedly elevated in cultured cells transfected with pol beta-bearing vectors as well as in embryos of the transgenic strains. The popular idea that DNA polymerase beta participates in DNA repair was not supported by the observation that a pair of a normal and a pol beta strain, and the other pair of a mei-9 mei-41 (DNA-repair deficient double mutations) strain and a pol beta mei-9 mei-41 strain, showed no difference in survival within each pair after treatment with ultraviolet light, methylmethane sulfonate and mitomycin C. The other idea that DNA polymerase beta participates in recombination was supported by the findings that spontaneous frequency of recombination, either meiotic or mitotic, is significantly higher in a transgenic pol beta strain than in a non-transgenic strain. The enhanced recombination frequency in the pol beta strain may, however, reflect an indirect effect of over-produced pol beta proteins on chromosomal stability. Whatever the direct effect of rat pol beta is, the transgenic pol beta flies will be useful for study of the physiological role of pol beta and the mechanism of recombination.


Asunto(s)
Reparación del ADN/genética , ADN Polimerasa Dirigida por ADN/genética , Drosophila melanogaster/genética , Recombinación Genética/genética , Animales , Animales Modificados Genéticamente , Técnicas de Transferencia de Gen , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...